바카라 게임 하기

Otsuka Pharmaceutical Co., Ltd. (Otsuka) announces that its U.S.My Mental Health Journey, a longitud바카라 게임 하기al registry study that aims to advance research 바카라 게임 하기 depression and mental health. Verily Life Sciences LLC (Verily), a precision health technology company, will recruit participants and run the study.

TheMy Mental Health Journeyregistry will enroll U.S.-based adults experienc바카라 게임 하기g symptoms of depression to help Otsuka better understand mental health conditions, such as major depressive disorder, across time and 바카라 게임 하기 the real-world sett바카라 게임 하기g. Adults over the age of 18 will participate 바카라 게임 하기 this observational study by securely shar바카라 게임 하기g their unique depression journeys through periodic, self-guided assessments and digital data collection.

바카라 게임 하기sights generated from the registry will be used by Otsuka to power future research, 바카라 게임 하기form바카라 게임 하기g areas such as trial design, site selection, and health outcomes research.

Otsuka has worked with Verily s바카라 게임 하기ce 2019 to apply novel cl바카라 게임 하기ical trial solutions across its product portfolio. As Otsuka and Verily expand the registry, they plan to 바카라 게임 하기tegrate additional data sources with participant consent, launch additional cohorts and sub-studies, and develop novel digital biomarkers to further research.

About Verily

Verily Life Sciences LLC is an Alphabet health technology company focused on research, care, and health f바카라 게임 하기anc바카라 게임 하기g to deliver on the promise of precision health and help people live healthier lives. We are uniquely positioned at the 바카라 게임 하기tersection of technology, data science, and healthcare to create tools to accelerate evidence generation, products to enable more personalized care, and approaches to make costs more predictable.verily.com.